25 research outputs found
Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related tumours
Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines
Autophagy Regulates the Liver Clock and Glucose Metabolism by Degrading CRY1
The circadian clock coordinates behavioral and circadian cues with availability and utilization of nutrients. Proteasomal degradation of clock repressors, such as cryptochrome (CRY) 1, maintains periodicity. Whether macroautophagy, a quality control pathway, degrades circadian proteins remains unknown. Here we show that circadian proteins BMAL1, CLOCK, REV-ERB alpha, and CRY1 are lysosomal targets, and that macroautophagy affects the circadian clock by selectively degrading CRY1. Autophagic degradation of CRY1, an inhibitor of gluconeogenesis, occurs in a diurnal window when rodents rely on gluconeogenesis, suggesting that CRY1 degradation is timeimprinted to maintenance of blood glucose. High-fat feeding accelerates autophagic CRY1 degradation and contributes to obesity-associated hyperglycemia. CRY1 contains several light chain 3 (LC3)-interacting region (LIR) motifs, which facilitate the interaction of cargo proteins with the autophagosome marker LC3. Using mutational analyses, we identified two distinct LIRs on CRY1 that exert circadian glycemic control by regulating CRY1 degradation, revealing LIRs as potential targets for controlling hyperglycemia.Peer reviewe
A simple matter of life and death : the trials of postnatal beta-cell mass regulation
Pancreatic beta-cells, which secrete the hormone insulin, are the key arbiters of glucose homeostasis. Defective beta-cell numbers and/or function underlie essentially all major forms of diabetes and must be restored if diabetes is to be cured. Thus, the identification of the molecular regulators of beta-cell mass and a better understanding of the processes of beta-cell differentiation and proliferation may provide further insight for the development of new therapeutic targets for diabetes. This review will focus on the principal hormones and nutrients, as well as downstream signalling pathways regulating beta-cell mass in the adult. Furthermore, we will also address more recently appreciated regulators of beta-cell mass, such as microRNAs
RELATIONSHIP OF GENETIC VARIATIONS OF THE GENE CODING FOR THE HUMAN EQUILIBRATIVE NUCLEOSIDE TRANSPORTER-1 (HENT1) WITH PROTEIN EXPRESSION AND RESPONSE TO TREATMENT IN CHRONIC HEPATITIS C
Stretch reduces nephrin expression via an angiotensin II-AT(1)-dependent mechanism in human podocytes: effect of rosiglitazone
Differential activation of Fyn kinase distinguishes saturated and unsaturated fats in mouse macrophages
Diet-induced obesity is associated with increased adipose tissue activated macrophages. Yet, how macrophages integrate fatty acid (FA) signals remains unclear. We previously demonstrated that Fyn deficiency (fynKO) protects against high fat diet-induced adipose tissue macrophage accumulation. Herein, we show that inflammatory markers and reactive oxygen species are not induced in fynKO bone marrow-derived macrophages exposed to the saturated FA palmitate, suggesting that Fyn regulates macrophage function in response to FA signals. Palmitate activates Fyn and re-localizes Fyn into the nucleus of RAW264.7, J774 and wild-type bone marrow-derived macrophages. Similarly, Fyn activity is increased in cells of adipose tissue stromal vascular fraction of high fat-fed control mice, with Fyn protein being located in the nucleus of these cells. We demonstrate that Fyn modulates palmitate-dependent oxidative stress in macrophages. Moreover, Fyn catalytic activity is necessary for its nuclear re-localization and downstream effects, as Fyn pharmacological inhibition abolishes palmitate-induced Fyn nuclear redistribution and palmitate-dependent increase of oxidative stress markers. Importantly, mono-or polyunsaturated FAs do not activate Fyn, and fail to re-localize Fyn to the nucleus. Together these data demonstrate that macrophages integrate nutritional FA signals via a differential activation of Fyn that distinguishes, at least partly, the effects of saturated versus unsaturated fats
The obesity gene and colorectal cancer risk: a population study in northern Italy
Background: Representing the second cause of cancer-related death after lung cancer in men and breast
cancer in women, colorectal cancer (CRC) is a major health problemin Italy. Obesity is reckoned to favor CRC;
however, the underlying mechanisms are unclear. Recently, a single nucleotide polymorphism (SNP) in the
fat mass and obesity associated (FTO) gene was found to be significantly associated with obesity.
Aims: To establish whether the FTO SNP rs9939609 may represent a risk factor for CRC and adenoma in the
Italian population.
Patients and methods: 1,037 subjects were enrolled in the study and divided in 3 groups: CRC (341 pts., M/
F=197/144, mean age=65.17±11.16 years), colorectal adenoma (385 pts., M/F=247/138, mean
age=62.49±13.01 years), healthy controls (311 pts., M/F=150/161, mean age=57.31±13.84 years).
DNA was extracted from whole blood, and stored frozen for rs9939609 genotyping by real-time PCR.
Results: The frequency of the obesity-associatedmutated A allele (AA+AT) on the FTO gene was 69.77% among
controls, and 71.85% and 65.71% respectively among CRC and polyp patients. Compared to control subjects
the AA+AT genotype had no significant effect on the risk for either CRC (OR=1.106; CI 95%=0.788–1.550;
p=0.561) or colorectal adenomas (OR=0.830; CI 95%=0.602–1.144; p=0.255). We did not observe any
association between the AA genotype and CRC/polyp localization and age at diagnosis. As measured in a
patient subset, carriership of the risk alleles did not reflect in a significantly altered BMI.
Conclusion: The obesity-linked FTO variants do not play a significant role in modulating the colorectal
cancer risk in the Italian population